DIMENSIONAL FUND ADVISORS LP

Position in ZYME — Zymeworks Inc.

CIK 354204 AUSTIN, TX

Position in ZYME

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$28,523,938

-$1,998,190 QoQ

Shares Held

1,139,135

-1.7% QoQ

Ownership

1.56%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 89% Shared 6% None 5%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ZYME ranks #44 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$28,523,938	1,139,135	-1.7%	Shares	Sole	2026-05-07
2025-12-31	$30,522,128	1,159,215	-2.7%	Shares	Sole	2026-02-12
2025-09-30	$20,339,510	1,190,838	-0.1%	Shares	Sole	2025-11-12
2025-06-30	$14,965,020	1,192,432	+10.5%	Shares	Sole	2025-08-12
2025-03-31	$12,856,343	1,079,458	+11.0%	Shares	Sole	2025-05-13
2024-12-31	$14,240,940	972,742	+14.5%	Shares	Sole	2025-02-13
2024-09-30	$10,661,248	849,502	+18.7%	Shares	Sole	2024-11-07
2024-06-30	$6,090,027	715,632	+127.5%	Shares	Sole	2024-08-09
2024-03-31	$3,309,212	314,564	-8.1%	Shares	Sole	2024-05-10
2023-12-31	$3,555,613	342,215	-2.0%	Shares	Sole	2024-02-07
2023-09-30	$2,213,921	349,199	+288.9%	Shares	Sole	2023-11-09
2023-06-30	$775,810	89,793	0.0%	Shares	Sole	2023-08-09
2023-03-31	$811,728	89,793	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.